Axsome Therapeutics (AXSM) Net Equity Issued and Repurchased (2016 - 2026)
Axsome Therapeutics' Net Equity Issued and Repurchased was $13.47 million in Q2 2026, down 58.7% from $32.63 million a year earlier but up 112.4% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Axsome Therapeutics' Net Equity Issued and Repurchased was $35.44 million through Jun 30, 2026, down 56.7% year-over-year; for FY2025, it was $67.9 million, up 66.5% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 36.9% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $40.78 million in FY2024 (-84.2%), $258.75 million in FY2023 (+6.1%), $243.76 million in FY2022 and $7.44 million in FY2021 (-47.4%).
- Quarterly Net Equity Issued and Repurchased has moved between $223,633 (Q4 2021) and $224.61 million (Q2 2023) over five years.
- Compared with a year earlier, Net Equity Issued and Repurchased has declined for four straight quarters, with growth averaging 97.3% over the last seven quarters.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q1 2025 (growth of 685.7%); the worst was Q1 2023 (a decline of 98.8%).
- Per Business Quant data, AXSM's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $6.34 million (Q1 2026), $5.68 million (Q4 2025) and $9.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | - |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | - |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | - |
| 10 | Axsome Therapeutics | 9.52 Bn | 8.25 Bn | 204.81 Mn | 13.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.47 Mn |
| Mar 31, 2026 | 6.34 Mn |
| Dec 31, 2025 | 5.68 Mn |
| Sep 30, 2025 | 9.95 Mn |
| Jun 30, 2025 | 32.63 Mn |
| Mar 31, 2025 | 19.65 Mn |
| Dec 31, 2024 | 16.42 Mn |
| Sep 30, 2024 | 13.10 Mn |
| Jun 30, 2024 | 8.76 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Sep 30, 2023 | 33.75 Mn |
| Jun 30, 2023 | 224.61 Mn |
| Mar 31, 2023 | 387,000.00 |
| Sep 30, 2022 | 180.20 Mn |
| Jun 30, 2022 | 32.55 Mn |
| Mar 31, 2022 | 31.01 Mn |
| Dec 31, 2021 | 223,633.00 |
| Jun 30, 2021 | 1.10 Mn |
| Mar 31, 2021 | 6.12 Mn |
| Dec 31, 2020 | 2.05 Mn |
API Access
Axsome Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();